Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.

Sudo K, Kato K, Matsuzaki J, Boku N, Abe S, Saito Y, Daiko H, Takizawa S, Aoki Y, Sakamoto H, Niida S, Takeshita F, Fukuda T, Ochiya T.

JAMA Netw Open. 2019 May 3;2(5):e194573. doi: 10.1001/jamanetworkopen.2019.4573. Erratum in: JAMA Netw Open. 2019 Jun 5;2(6):e197401.

PMID:
31125107
2.

A novel serum microRNA signature to screen esophageal squamous cell carcinoma.

Huang Z, Zhang L, Zhu D, Shan X, Zhou X, Qi LW, Wu L, Zhu J, Cheng W, Zhang H, Chen Y, Zhu W, Wang T, Liu P.

Cancer Med. 2017 Jan;6(1):109-119. doi: 10.1002/cam4.973. Epub 2016 Dec 30.

3.

A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.

Zhou X, Wen W, Zhu J, Huang Z, Zhang L, Zhang H, Qi LW, Shan X, Wang T, Cheng W, Zhu D, Yin Y, Chen Y, Zhu W, Shu Y, Liu P.

Oncotarget. 2017 May 23;8(21):34468-34480. doi: 10.18632/oncotarget.16519.

4.

Serum MicroRNA-Based Risk Prediction for Stroke.

Sonoda T, Matsuzaki J, Yamamoto Y, Sakurai T, Aoki Y, Takizawa S, Niida S, Ochiya T.

Stroke. 2019 Jun;50(6):1510-1518. doi: 10.1161/STROKEAHA.118.023648. Epub 2019 Apr 15.

PMID:
31136284
5.

Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.

Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X, Zhang Y, Chen X, Wang J, Zen K, Zhang CY, Zhang C.

PLoS One. 2014 Mar 20;9(3):e92292. doi: 10.1371/journal.pone.0092292. eCollection 2014.

6.

Identification of Serum MicroRNAs as Novel Biomarkers in Esophageal Squamous Cell Carcinoma Using Feature Selection Algorithms.

Zheng D, Ding Y, Ma Q, Zhao L, Guo X, Shen Y, He Y, Wei W, Liu F.

Front Oncol. 2019 Jan 21;8:674. doi: 10.3389/fonc.2018.00674. eCollection 2018.

7.

Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy.

Niwa Y, Yamada S, Sonohara F, Kurimoto K, Hayashi M, Tashiro M, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y.

J Transl Med. 2019 Jan 3;17(1):1. doi: 10.1186/s12967-018-1762-6.

8.

Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.

Zhang C, Wang C, Chen X, Yang C, Li K, Wang J, Dai J, Hu Z, Zhou X, Chen L, Zhang Y, Li Y, Qiu H, Xing J, Liang Z, Ren B, Yang C, Zen K, Zhang CY.

Clin Chem. 2010 Dec;56(12):1871-9. doi: 10.1373/clinchem.2010.147553. Epub 2010 Oct 13.

9.

Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.

Liu F, Tian T, Xia LL, Ding Y, Cormier RT, He Y.

Dis Esophagus. 2017 Feb 1;30(2):1-9. doi: 10.1111/dote.12489.

PMID:
27003597
10.

miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.

Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ.

J Thorac Oncol. 2011 Mar;6(3):482-8. doi: 10.1097/JTO.0b013e318208c785.

11.

Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.

He FC, Meng WW, Qu YH, Zhou MX, He J, Lv P, Ming L.

World J Gastroenterol. 2015 Apr 21;21(15):4660-5. doi: 10.3748/wjg.v21.i15.4660.

12.

A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.

Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ, Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, Jia WH, Jie Y, Chen MS, Chen MX, Fang JH, Zeng C, Zhang Y, Guo RP, Wu Y, Lin G, Zheng L, Zhuang SM.

Lancet Oncol. 2015 Jul;16(7):804-15. doi: 10.1016/S1470-2045(15)00048-0. Epub 2015 Jun 15.

PMID:
26088272
13.

Identification of Novel Circulating miRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia.

Shen Y, Ding Y, Ma Q, Zhao L, Guo X, Shao Y, Niu C, He Y, Zhang F, Zheng D, Wei W, Liu F.

Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1212-1220. doi: 10.1158/1055-9965.EPI-18-1199. Epub 2019 Apr 15.

PMID:
30988139
14.

[Serum levels of miRNA-183 in patients with esophageal squamous cell carcinoma and its diagnostic value].

Chen J, Chen M.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Oct 28;43(10):1048-1053. doi: 10.11817/j.issn.1672-7347.2018.10.002. Chinese.

15.

Serum miRNA expression in patients with esophageal squamous cell carcinoma.

Hui B, Chen X, Hui L, Xi R, Zhang X.

Oncol Lett. 2015 Nov;10(5):3008-3012. Epub 2015 Aug 25.

16.

Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.

Cui Y, Xue Y, Dong S, Zhang P.

J Int Med Res. 2017 Aug;45(4):1310-1317. doi: 10.1177/0300060517709370. Epub 2017 Jun 6.

17.

Circulating microRNAs in esophageal squamous cell carcinoma: association with locoregional staging and survival.

Li BX, Yu Q, Shi ZL, Li P, Fu S.

Int J Clin Exp Med. 2015 May 15;8(5):7241-50. eCollection 2015.

18.

Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.

Xu H, Yang Y, Zhao H, Yang X, Luo Y, Ren Y, Liu W, Li N.

Tumour Biol. 2016 Jan;37(1):447-53. doi: 10.1007/s13277-015-3514-z. Epub 2015 Jul 30.

PMID:
26224475
19.

The expression of microRNA 574-3p as a predictor of postoperative outcome in patients with esophageal squamous cell carcinoma.

Okumura T, Kojima H, Miwa T, Sekine S, Hashimoto I, Hojo S, Nagata T, Shimada Y.

World J Surg Oncol. 2016 Aug 26;14(1):228. doi: 10.1186/s12957-016-0985-3.

20.

MicroRNA biomarkers in whole blood for detection of pancreatic cancer.

Schultz NA, Dehlendorff C, Jensen BV, Bjerregaard JK, Nielsen KR, Bojesen SE, Calatayud D, Nielsen SE, Yilmaz M, Holländer NH, Andersen KK, Johansen JS.

JAMA. 2014 Jan 22-29;311(4):392-404. doi: 10.1001/jama.2013.284664.

PMID:
24449318

Supplemental Content

Support Center